PHARMACEUTICALLY ACCEPTABLE SALT OF ALKYLCARBAMOYL NAPHTHALENYLOXY OCTENOYLHYDROXYAMIDE OR OF DERIVATIVE THEREOF AND METHOD FOR PREPARING SAME

WIPO Patent Application WO/2018/230829

A1

The present invention relates to a pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide or of a derivative thereof and a method for preparing same, and can improve moisture stability while maintaining the characteristics, such as the efficacy and effective dose, of a pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide or of a derivative thereof. In addition, the present invention can simplify the production and manufacturing process of a formulation by improving hygroscopicity.

WO/2022/202402	SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD AND COMPOSITION FOR FORMING RESIST UNDERLAYER FILM
JP2019151630	POLYFUNCTIONAL COMPOUND AND METHOD FOR PRODUCING THE SAME, AMIC ACID COMPOUND AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING IMIDE COMPOUND
JP6800320	Organic amine salt compounds with anions as CO2 donors and their use as foaming agents

CHO JAE PYOUNG (KR)
JUNG YONG HO (KR)
CHO JOONG MYUNG (KR)

PCT/KR2018/004466

December 20, 2018

April 18, 2018

Click for automatic bibliography generation  

CRYSTALGENOMICS INC (KR)

C07C271/02; A61K31/16

KR100814092B1	2008-03-14
KR20070101284A	2007-10-16
KR100696139B1	2007-03-20
KR101388596B1	2014-04-24
KR100814092B1	2008-03-14

HWANG, J. J. ET AL.: "A Novel Histone Deacetylase Inhibitor, CG0006, Induces Cell Death through Both Extrinsic and Intrinsic Apoptotic Pathways", ANTI-CANCER DRUGS, vol. 20, no. 9, 2009, pages 815 - 821, XP009517492, DOI: 10.1097/CAD.0b013e3283300a0f
See also references of EP 3640239A4

KIM, Aera (KR)

View/Download PDF      PDF Help

Previous Patent: DISTANCE MEASURING APPARATUS AND CONTROL METHOD THEREFOR

Next Patent: VACUUM CLEANER